Ensysce Biosciences, Inc. (ENSC) earnings
ENSC earnings moved a median of +0.82% by the close. Quarterly and annual ENSC reports and results, each read against the price at its own news timestamp. Back to the ENSC overview →
21 measured ENSC earnings events.
Where these ENSC earnings landedvs 21 measured ENSC earnings reactions
| Middle 50% of ENSC earnings reactions | -2.83% to +10.00% |
|---|---|
| Median reaction (to close) | +0.82% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 ENSC earnings events with a measured close landed between -2.83% and +10.00%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +1.59% | +17.93% | |
| Form 10-Q Ensysce Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +1.59% | +17.93% | |
| Ensysce Biosciences Reports First Quarter 2026 Financial Results | Press release | -4.33% | +24.90% | |
| Form 10-Q Ensysce Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -4.33% | +24.90% | |
| Form 10-K Ensysce Biosciences, For: Dec 31 | SEC filing · Form 10-K | -1.71% | +6.91% | |
| Ensysce Biosciences Reports Third Quarter 2025 Financial Results | Press release | -0.50% | -2.49% | |
| Form 10-Q Ensysce Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -0.50% | -2.49% | |
| Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates | Press release | -2.83% | -2.83% | |
| Form 10-Q Ensysce Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -2.83% | -2.83% | |
| Ensysce Biosciences Reports First Quarter 2025 Financial Results | Press release | +3.33% | +10.00% | |
| Form 10-Q Ensysce Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +3.33% | +10.00% | |
| Form 10-K Ensysce Biosciences, For: Dec 31 | SEC filing · Form 10-K | +4.49% | -1.92% | |
| Ensysce Biosciences Reports Third Quarter 2024 Financial Results | Press release | -4.79% | -11.38% | |
| Form 10-Q Ensysce Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -4.79% | -11.38% | |
| Ensysce Biosciences Reports Second Quarter 2024 Financial Results | Press release | +0.00% | +0.82% | |
| Form 10-Q Ensysce Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.82% | |
| Ensysce Biosciences Reports First Quarter 2024 Financial Results | Press release | +6.80% | +6.36% | |
| Form 10-Q Ensysce Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +6.80% | +6.36% | |
| Form 10-K Ensysce Biosciences, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.81% | |
| Ensysce Biosciences Reports Third Quarter 2023 Financial Results | Press release | -2.86% | -7.48% | |
| Form 10-Q Ensysce Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -2.86% | -7.48% |
Keep exploring
More ENSC: analyst actions → · SEC filings → · ENSC overview →